HUP0200117A2 - Tápkeverékek és eljárások - Google Patents

Tápkeverékek és eljárások

Info

Publication number
HUP0200117A2
HUP0200117A2 HU0200117A HUP0200117A HUP0200117A2 HU P0200117 A2 HUP0200117 A2 HU P0200117A2 HU 0200117 A HU0200117 A HU 0200117A HU P0200117 A HUP0200117 A HU P0200117A HU P0200117 A2 HUP0200117 A2 HU P0200117A2
Authority
HU
Hungary
Prior art keywords
nutritional
mixture
castration
ovary
methods
Prior art date
Application number
HU0200117A
Other languages
English (en)
Inventor
Geza Bruckner
József Szabó
Original Assignee
Geza Bruckner
József Szabó
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geza Bruckner, József Szabó filed Critical Geza Bruckner
Publication of HUP0200117A2 publication Critical patent/HUP0200117A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tápkeverékekre és eljárásokra vonatkozik, ahol atápkeverék alapanyaga mellett egy olyan tápkiegészítő anyagotalkalmaznak, mely elégendő mennyiségben tartalmaz ösztrogént,androgént vagy ezek keverékét ahhoz, hogy emlősöknél azivartalanítást, kasztrálást, miskárolást, a petefészek eltávolítását,a petefészek és méh együttes eltávolítását, vagy a klimaxot követőenszokásosan bekövetkező testsúlygyarapodás mértékét csökkentsék. Atápkiegészítő anyag előnyösen fitoösztrogént, fitoandrogént, vagy ezekkeverékét tartalmazza. A találmány szerinti tápkeverékek szabályosidőközönként, előnyösen naponta adhatóak. Ó
HU0200117A 1999-02-24 2000-02-24 Tápkeverékek és eljárások HUP0200117A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12133899P 1999-02-24 1999-02-24

Publications (1)

Publication Number Publication Date
HUP0200117A2 true HUP0200117A2 (hu) 2002-05-29

Family

ID=22396033

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200117A HUP0200117A2 (hu) 1999-02-24 2000-02-24 Tápkeverékek és eljárások

Country Status (16)

Country Link
US (3) US6359017B1 (hu)
EP (1) EP1158872B1 (hu)
JP (1) JP2002536988A (hu)
CN (1) CN1279843C (hu)
AT (1) ATE549939T1 (hu)
AU (1) AU770075B2 (hu)
BR (1) BR0008449A (hu)
CA (1) CA2365078C (hu)
ES (1) ES2384452T3 (hu)
HK (1) HK1043920A1 (hu)
HU (1) HUP0200117A2 (hu)
MX (1) MXPA01008598A (hu)
RU (1) RU2267279C2 (hu)
UA (1) UA74779C2 (hu)
WO (1) WO2000049896A1 (hu)
ZA (1) ZA200107017B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001253070A1 (en) * 2000-03-31 2001-10-15 Jonathan Ingram Isoflavones for treatment of obesity
US20030109679A1 (en) * 2001-10-10 2003-06-12 Green Brent Everett Flax protein isolate and production
EP1388297A1 (en) * 2002-08-06 2004-02-11 Nestec S.A. Calcium absorption enhancer
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
US20040253319A1 (en) * 2003-06-11 2004-12-16 Shrirang Netke Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy
JP4330627B2 (ja) * 2003-08-01 2009-09-16 バーコン ニュートラサイエンス （エムビー） コーポレイション 亜麻タンパク質単離物の調製方法
EP1541040A1 (de) * 2003-12-04 2005-06-15 Cognis Iberia S.L Zubereitung zur oralen Aufnahme (VI) enthaltend einen Extrakt oder Wirkstoffe der Pflanze Medicago sativa
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
WO2005065667A2 (en) * 2003-12-29 2005-07-21 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
DE602005022431D1 (de) * 2004-03-17 2010-09-02 Nestec Sa Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit
CN1980682A (zh) 2004-05-10 2007-06-13 丹麦皇家兽医和农业学院 用于控制体重的亚麻子
EP1841421A4 (en) * 2005-01-10 2008-01-02 Hormos Medical Ltd USE OF LIGNAN IN THE PREPARATION TO PREVENT OR RELIEVE SYMPTOMS OF ESTROGEN FAILURE
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
CA2627915C (en) * 2005-11-02 2015-02-03 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
JP2008120729A (ja) * 2006-11-13 2008-05-29 Kao Corp Ｆｘｒ活性化剤
EP2190303A1 (en) 2007-09-12 2010-06-02 Københavns Universitet Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
ITBA20080008A1 (it) * 2008-02-22 2009-08-23 Michele Barone Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
RU2513133C2 (ru) * 2008-08-15 2014-04-20 Нестек С.А. Способы усиления энергетического обмена
ITPI20110034A1 (it) * 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso femminile.
EP2696692A4 (en) * 2011-04-15 2014-10-01 Nestec Sa METHOD FOR REGULATING SIRTUINE GENE EXPRESSION
JP6051436B2 (ja) * 2011-12-07 2016-12-27 国立研究開発法人産業技術総合研究所 レッドクローバーと亜麻種子由来のエストロゲン類似活性組成物
AU2014238147B2 (en) 2013-03-15 2019-01-31 Mars, Incorporated Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting
ES2825064T3 (es) * 2013-03-15 2021-05-14 Mars Inc Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático
WO2018075641A1 (en) * 2016-10-19 2018-04-26 Longevica Therapeutics Inc. Methods and compositions for extending lifespan
KR102371575B1 (ko) * 2019-12-13 2022-03-08 주식회사 봄헬스케어 중성화된 수컷 반려동물용 식품 조성물
KR102371548B1 (ko) * 2019-12-13 2022-03-08 주식회사 봄헬스케어 중성화된 암컷 반려동물용 식품 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166380B (hu) * 1973-07-09 1975-03-28
US4096254A (en) * 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
US4282254A (en) * 1979-10-04 1981-08-04 General Foods Corporation Dog food of improved acceptability
WO1994023716A1 (en) * 1993-04-16 1994-10-27 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
US5424331A (en) * 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
JPH0923822A (ja) * 1995-07-14 1997-01-28 Nichimo Co Ltd ペプチド生成物およびその製造方法
JPH09255570A (ja) 1996-03-21 1997-09-30 Fujitsuko Kk 血中脂質濃度を低減させる薬剤及び可食性組成物
EP0834262A4 (en) * 1996-04-10 1999-03-24 Nichimo Kk FABRIC WITH A HEALTH-ENHANCING COMPONENT AND METHOD FOR THE PRODUCTION THEREOF
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
US6132795A (en) 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
AU4573899A (en) 1998-06-19 2000-01-05 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women
US6086886A (en) * 1998-10-22 2000-07-11 Jarrow Formulas, Inc. Composition for promoting intestinal health

Also Published As

Publication number Publication date
US6359017B1 (en) 2002-03-19
CN1279843C (zh) 2006-10-18
US20020091110A1 (en) 2002-07-11
AU770075B2 (en) 2004-02-12
BR0008449A (pt) 2002-05-14
AU3603600A (en) 2000-09-14
ZA200107017B (en) 2002-08-26
WO2000049896A1 (en) 2000-08-31
US20040248822A1 (en) 2004-12-09
UA74779C2 (en) 2006-02-15
ES2384452T3 (es) 2012-07-05
HK1043920A1 (zh) 2002-10-04
EP1158872B1 (en) 2012-03-21
CN1348334A (zh) 2002-05-08
JP2002536988A (ja) 2002-11-05
CA2365078A1 (en) 2000-08-31
CA2365078C (en) 2007-02-20
EP1158872A1 (en) 2001-12-05
MXPA01008598A (es) 2003-06-24
ATE549939T1 (de) 2012-04-15
RU2267279C2 (ru) 2006-01-10

Similar Documents

Publication Publication Date Title
HUP0200117A2 (hu) Tápkeverékek és eljárások
HUP0100121A3 (en) Pharmaceutical compositions for the treatment of conditions responsive to testosterone elevation
HUP0102483A2 (hu) Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények
HUP0302492A3 (en) Methods and compositions for the prevention of tolerance to medications
HK1059215A1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
HUP0202395A2 (hu) Szőlőmagok, hidegen préselt szőlőmagolaj, szőlőmagdara és szőlőmagliszt
IL141081A0 (en) Use of biogenic estrogen sulfamates for the production of pharmaceutical compositions and pharmaceutical compositions containing biogenic estrogen sulfamates
ATE322901T1 (de) Maca und geweih zur steigerung des testosteronspiegels
BG102673A (en) Mixtures produced from grains of eugenia jambolana lamarck, their preparation and application and some of their components as medicinal forms
EP1781107A4 (en) PHYTOPHARMACEUTICAL COMPOSITIONS FOR PREVENTING AND / OR TREATING CARDIOVASCULAR DISEASES AND PROCESS FOR PREPARING THEM
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
HK1082923A1 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency
TWI318879B (en) Powdered mixture of plant sterol and emulsifier and preparation thereof
MXPA04003499A (es) Utilizacion de cistationina.
BR0107701A (pt) Produtos alimentìcios e processos
IL161116A (en) Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary arterial hypertension
HUP0202638A2 (hu) Fermentált búzacsíra-kivonat alkalmazása gyulladáscsökkentő készítmények előállítására
MD1702G2 (ro) Compoziţie de ingrediente pentru obţinerea balsamului curativo-profilactic
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
GB0406912D0 (en) Pharmaceutical composition for prophylaxis or treatment of osteoporosis and method to prepare the same
IL161091A0 (en) Compositions for the treatment and prevention of plant pathogens
MD670G2 (ro) Remediu cu acţiune imunomodulatoare
HUP0204258A3 (en) Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
WO2002019842A3 (de) Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: THE PROCTER & GAMBLE CO., US

Free format text: FORMER OWNER(S): THE IAMS COMPANY, US; BRUCKNER, GEZA, US; SZABO JOZSEF, HU

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished